Immix Biopharma Competitors and Similar CompaniesClear all
Immix Biopharma's competitors and similar companies include Flare Therapeutics, CureVac, Puma Biotechnology and HUYA Bioscience International.
 Immix Biopharma Immix Biopharma is a biopharmaceutical company developing therapies for cancer patients. |  Flare Therapeutics Flare Therapeutics is a company that provides precision oncology solutions. It develops molecule medicines for patients. |  Puma Biotechnology Puma Biotechnology acquires and develops innovative products for the treatment of various forms of cancer. |  HUYA Bioscience International HUYA Bioscience International is a company specializing in the biopharmaceutical products. | ||
Founding Date | Founding Date 2012 | Founding Date 2021 | Founding Date 2000 | Founding Date 2010 | Founding Date 2004 |
Type | Type Public | Type Private | Type Public | Type Public | Type Private |
Tags | |||||
Locations | Locations Los Angeles, US HQ | Locations Cambridge, US HQ | Locations Tübingen, DE HQ Ottignies Louvain La Neuve, BE Wiesbaden, DE Amsterdam, NL Basel, CH Boston, US | Locations Los Angeles, US HQ | Locations San Diego, US HQ Chengdu Shi, CN Guangzhou Shi, CN Hangzhou, CN Shenzhen Shi, CN Shenzhen Shi, CN Suzhou Shi, CN see more |
Employees | Employees 11 | Employees 731% decrease | Employees 82517% decrease | Employees 27214% decrease | Employees 1113% increase |
Valuation ($) | Valuation ($) 46.9 m | Valuation ($) N/A | Valuation ($) 648.3 m | Valuation ($) 136.8 m | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) €535.2m (FY, 2024) | Revenue (est.) $228.4m (FY, 2025) | Revenue (est.) N/A |
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods €9.7m (FY, 2024) | Cost of goods $58.2m (FY, 2025) | Cost of goods N/A |
Gross profit | Gross profit N/A | Gross profit N/A | Gross profit €534.4m (FY, 2024) | Gross profit $170.2m (FY, 2025) | Gross profit N/A |
Net income | Net income ($29.4m) (FY, 2025) | Net income N/A | Net income €162.2m (FY, 2024) | Net income N/A | Net income N/A |
Funding | |||||
Latest funding round | Latest funding round N/A | Latest funding round $ 82m (about 5 years ago) | Latest funding round N/A | Latest funding round N/A | Latest funding round $ 7.6m (about 14 years ago) |
Total funding raised | Total funding raised N/A | Total funding raised $ 82m | Total funding raised $ 1.1b | Total funding raised $ 172m | Total funding raised $ 12.6m |
For sources of this data, please see the company profile
View Company Profiles
Flare Therapeutics
HQ
Cambridge, US
Employees
73↓ 1% decrease
Flare Therapeutics is a company that provides precision oncology solutions. It develops molecule medicines for patients.
View company
CureVac
HQ
Tübingen, DE
Employees
825↓ 17% decrease
CureVac is a biotechnology company offering messenger RNA (mRNA) technology.
View companyPuma Biotechnology
HQ
Los Angeles, US
Employees
272↓ 14% decrease
Puma Biotechnology acquires and develops innovative products for the treatment of various forms of cancer.
View companyHUYA Bioscience International
HQ
San Diego, US
Employees
111↑ 3% increase
HUYA Bioscience International is a company specializing in the biopharmaceutical products.
View company